These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16498501)

  • 1. Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody.
    Bales KR; Tzavara ET; Wu S; Wade MR; Bymaster FP; Paul SM; Nomikos GG
    J Clin Invest; 2006 Mar; 116(3):825-32. PubMed ID: 16498501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease.
    Watanabe T; Yamagata N; Takasaki K; Sano K; Hayakawa K; Katsurabayashi S; Egashira N; Mishima K; Iwasaki K; Fujiwara M
    Brain Res; 2009 Jan; 1249():222-8. PubMed ID: 18996097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.
    Dodart JC; Bales KR; Gannon KS; Greene SJ; DeMattos RB; Mathis C; DeLong CA; Wu S; Wu X; Holtzman DM; Paul SM
    Nat Neurosci; 2002 May; 5(5):452-7. PubMed ID: 11941374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons.
    Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S
    Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitation of memory impairment and cholinergic disturbance in a mouse model of Alzheimer's disease by mild ischemic burden.
    Watanabe T; Takasaki K; Yamagata N; Fujiwara M; Iwasaki K
    Neurosci Lett; 2013 Mar; 536():74-9. PubMed ID: 23295908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
    Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
    J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
    Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
    Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.
    Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T
    FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitters and energy metabolites in amyloid-bearing APP(SWE)xPSEN1dE9 Mouse Brain.
    Hartmann J; Kiewert C; Klein J
    J Pharmacol Exp Ther; 2010 Feb; 332(2):364-70. PubMed ID: 19846589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
    Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices.
    Kar S; Issa AM; Seto D; Auld DS; Collier B; Quirion R
    J Neurochem; 1998 May; 70(5):2179-87. PubMed ID: 9572306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pen-2 overexpression induces Aβ-42 production, memory defect, motor activity enhancement and feeding behavior dysfunction in NSE/Pen-2 transgenic mice.
    Nam SH; Seo SJ; Goo JS; Kim JE; Choi SI; Lee HR; Hwang IS; Jee SW; Lee SH; Bae CJ; Park JY; Kim HS; Shim SB; Hwang DY
    Int J Mol Med; 2011 Dec; 28(6):961-71. PubMed ID: 21822534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cholinergic system, circadian rhythmicity, and time memory.
    Hut RA; Van der Zee EA
    Behav Brain Res; 2011 Aug; 221(2):466-80. PubMed ID: 21115064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
    Zhang W; Bai M; Xi Y; Hao J; Liu L; Mao N; Su C; Miao J; Li Z
    Free Radic Biol Med; 2012 Apr; 52(8):1443-52. PubMed ID: 22342520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.